
Medical Analysis Systems, Inc.
Free shipping on orders over $99 · 30-day returns
TRI-POINT LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL is an FDA 510(k)-cleared medical device (K954322) manufactured by Medical Analysis Systems, Inc.. This device is classified under the Clinical Toxicology specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on October 10, 1995. Regulation: 8.